Logo image of 1RCAT.MI

RED CAT HOLDINGS INC (1RCAT.MI) Stock Fundamental Analysis

Europe - BIT:1RCAT - US75644T1007 - Common Stock

8.6 EUR
+0.12 (+1.42%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1RCAT. 1RCAT was compared to 54 industry peers in the Electronic Equipment, Instruments & Components industry. 1RCAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1RCAT is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year 1RCAT has reported negative net income.
1RCAT had a negative operating cash flow in the past year.
In the past 5 years 1RCAT always reported negative net income.
In the past 5 years 1RCAT always reported negative operating cash flow.
1RCAT.MI Yearly Net Income VS EBIT VS OCF VS FCF1RCAT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

1RCAT's Return On Assets of -55.70% is on the low side compared to the rest of the industry. 1RCAT is outperformed by 88.46% of its industry peers.
1RCAT's Return On Equity of -70.74% is on the low side compared to the rest of the industry. 1RCAT is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
ROA -55.7%
ROE -70.74%
ROIC N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
1RCAT.MI Yearly ROA, ROE, ROIC1RCAT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for 1RCAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RCAT.MI Yearly Profit, Operating, Gross Margins1RCAT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

6

2. Health

2.1 Basic Checks

1RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
1RCAT has more shares outstanding than it did 1 year ago.
1RCAT has a better debt/assets ratio than last year.
1RCAT.MI Yearly Shares Outstanding1RCAT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2020 2021 2022 2023 2024 20M 40M 60M
1RCAT.MI Yearly Total Debt VS Total Assets1RCAT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

1RCAT has an Altman-Z score of 21.32. This indicates that 1RCAT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 21.32, 1RCAT belongs to the top of the industry, outperforming 98.08% of the companies in the same industry.
1RCAT has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
1RCAT has a Debt to Equity ratio of 0.20. This is in the better half of the industry: 1RCAT outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 21.32
ROIC/WACCN/A
WACC9.4%
1RCAT.MI Yearly LT Debt VS Equity VS FCF1RCAT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

1RCAT has a Current Ratio of 3.80. This indicates that 1RCAT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.80, 1RCAT belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
1RCAT has a Quick Ratio of 2.92. This indicates that 1RCAT is financially healthy and has no problem in meeting its short term obligations.
1RCAT's Quick ratio of 2.92 is amongst the best of the industry. 1RCAT outperforms 90.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 2.92
1RCAT.MI Yearly Current Assets VS Current Liabilites1RCAT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

1RCAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.31%.
Looking at the last year, 1RCAT shows a very strong growth in Revenue. The Revenue has grown by 79.98%.
1RCAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.80% yearly.
EPS 1Y (TTM)-17.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)79.98%
Revenue growth 3Y52.8%
Revenue growth 5YN/A
Sales Q2Q%15.94%

3.2 Future

Based on estimates for the next years, 1RCAT will show a very strong growth in Earnings Per Share. The EPS will grow by 39.49% on average per year.
1RCAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 123.37% yearly.
EPS Next Y-7.95%
EPS Next 2Y49.03%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue Next Year321.55%
Revenue Next 2Y191%
Revenue Next 3Y123.37%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1RCAT.MI Yearly Revenue VS Estimates1RCAT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
1RCAT.MI Yearly EPS VS Estimates1RCAT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1RCAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 114.17, which means the current valuation is very expensive for 1RCAT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1RCAT indicates a slightly more expensive valuation: 1RCAT is more expensive than 65.38% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.89. 1RCAT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 114.17
1RCAT.MI Price Earnings VS Forward Price Earnings1RCAT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RCAT.MI Per share data1RCAT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as 1RCAT's earnings are expected to grow with 39.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.03%
EPS Next 3Y39.49%

More info and screens

0

5. Dividend

5.1 Amount

1RCAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RED CAT HOLDINGS INC

BIT:1RCAT (9/26/2025, 7:00:00 PM)

8.6

+0.12 (+1.42%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)09-23 2025-09-23
Inst Owners18.24%
Inst Owner ChangeN/A
Ins Owners14.17%
Ins Owner ChangeN/A
Market Cap857.94M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-89.99%
Min EPS beat(2)-152.1%
Max EPS beat(2)-27.88%
EPS beat(4)0
Avg EPS beat(4)-100.39%
Min EPS beat(4)-152.1%
Max EPS beat(4)-27.88%
EPS beat(8)1
Avg EPS beat(8)-86.46%
EPS beat(12)2
Avg EPS beat(12)-132.75%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-46.29%
Min Revenue beat(2)-59.15%
Max Revenue beat(2)-33.43%
Revenue beat(4)0
Avg Revenue beat(4)-64.67%
Min Revenue beat(4)-92.04%
Max Revenue beat(4)-33.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-30%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-15.8%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.54%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 114.17
P/S 145.46
P/FCF N/A
P/OCF N/A
P/B 10.54
P/tB 14.34
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)0.08
Fwd EY0.88%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.06
BVpS0.82
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.7%
ROE -70.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.37%
Cap/Sales 9.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.8
Quick Ratio 2.92
Altman-Z 21.32
F-Score3
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)137.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-7.95%
EPS Next 2Y49.03%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue 1Y (TTM)79.98%
Revenue growth 3Y52.8%
Revenue growth 5YN/A
Sales Q2Q%15.94%
Revenue Next Year321.55%
Revenue Next 2Y191%
Revenue Next 3Y123.37%
Revenue Next 5YN/A
EBIT growth 1Y22.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.63%
EBIT Next 3Y56.58%
EBIT Next 5YN/A
FCF growth 1Y40.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.43%
OCF growth 3YN/A
OCF growth 5YN/A